Factors Affecting Axillary Complete Response After Neoadjuvant Chemotherapy and the Importance of Ki-67 Level

We determined independent predictive factors influencing axillary response in patients with neoadjuvant chemotherapy (NAC) indication due to axillary metastases. The patients with T1-4, N1, and M0 tumors who underwent NAC were selected. The study included 105 patients, all women. The factors to be i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of surgery 2023-02, Vol.85 (1), p.113-119
Hauptverfasser: Koca, Bulent, Yildirim, Murat, Ugurlu, Celil, Bostan, Mustafa Sami, Başak, Mustafa, Dasıran, Mehmet Fatih, Özcan, Namık
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 119
container_issue 1
container_start_page 113
container_title Indian journal of surgery
container_volume 85
creator Koca, Bulent
Yildirim, Murat
Ugurlu, Celil
Bostan, Mustafa Sami
Başak, Mustafa
Dasıran, Mehmet Fatih
Özcan, Namık
description We determined independent predictive factors influencing axillary response in patients with neoadjuvant chemotherapy (NAC) indication due to axillary metastases. The patients with T1-4, N1, and M0 tumors who underwent NAC were selected. The study included 105 patients, all women. The factors to be investigated for their effect on the axillary response to NAC were determined as the following: menopausal status (premenopause, postmenopause), pathological diagnosis (invasive ductal ca, other), radiological tumor size (T1 
doi_str_mv 10.1007/s12262-022-03633-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2778325109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2778325109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-c11a1965cc5f5b6ac17ef42176711c0ae80a8171a50818c090874a0ed93857e3</originalsourceid><addsrcrecordid>eNp9kEFLAzEQhYMoWKt_wFPA8-ok6W6yx1KsFouC9B5iOttu2d2sSVrsvzd2BW8ehnmH771hHiG3DO4ZgHwIjPOCZ8DTiEKITJ2REZRSZKUsxflJ84xDoS7JVQg7AD5J2Ii0c2Oj84FOqwptrLsNnX7VTWP8kc5c2zcYkb5j6F0XMEERPX1FZ9a7_cF0kc622Lq4RW_6IzXdmiZNF23vfDSdReoq-lJnhaRLPGBzTS4q0wS8-d1jspo_rmbP2fLtaTGbLjPLJcTMMmZYWeTW5lX-URjLJFYTzmQhGbNgUIFRTDKTg2LKQglKTgzguhQqlyjG5G6I7b373GOIeuf2vksXNZdSCZ4zKBPFB8p6F4LHSve-btPjmoH-aVUPrerUqj61qlUyicEUEtxt0P9F_-P6BjOMec0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2778325109</pqid></control><display><type>article</type><title>Factors Affecting Axillary Complete Response After Neoadjuvant Chemotherapy and the Importance of Ki-67 Level</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SpringerNature Journals</source><creator>Koca, Bulent ; Yildirim, Murat ; Ugurlu, Celil ; Bostan, Mustafa Sami ; Başak, Mustafa ; Dasıran, Mehmet Fatih ; Özcan, Namık</creator><creatorcontrib>Koca, Bulent ; Yildirim, Murat ; Ugurlu, Celil ; Bostan, Mustafa Sami ; Başak, Mustafa ; Dasıran, Mehmet Fatih ; Özcan, Namık</creatorcontrib><description>We determined independent predictive factors influencing axillary response in patients with neoadjuvant chemotherapy (NAC) indication due to axillary metastases. The patients with T1-4, N1, and M0 tumors who underwent NAC were selected. The study included 105 patients, all women. The factors to be investigated for their effect on the axillary response to NAC were determined as the following: menopausal status (premenopause, postmenopause), pathological diagnosis (invasive ductal ca, other), radiological tumor size (T1 &lt; 2 cm, T2 ≥ 2- &lt; 5 cm, T3 ≥ 5 cm), estrogen receptor (positive, negative), progesterone receptor (positive, negative), HER2 (positive, negative), Ki-67 (cut-off 14%), Ki-67 (cut-off 25%), luminal A, luminal B, HER 2-positive groups, triple-negative group, the number of positive lymph nodes in the axilla before NAC (1, &gt; 1), multifocal tumor, and inflammatory breast cancer. The axillary response to NAC was detected to be lower in ER + ( p  = 0.001), PR + ( p  = 0.002), luminal A ( p  &lt; 0.001), the number of pathological lymph nodes before NAC &gt; 1 ( p  = 0.018), multifocality ( p  = 0.04), and inflammatory breast cancer ( p  = 0.018). We observed that the axillary response to NAC was better in HER2 + ( p  = 0.09), Ki-67 (cut-off 14%) ( p  &lt; 0.001), Ki-67 (cut-off 25) ( p  &lt; 0.001), HER2 + subs type ( p  = 0.023), triple negative subtype ( p  = 0.046). According to the results of the multivariate logistic regression test performed Ki-67 (cut-off 25%) ( p  = 0.030) and inflammatory type breast cancer ( p  = 0.013) were found to be independent predictive factors affecting axillary response to NAC. We recommend that the Ki-67 value of 25% be used to predict axillary response in luminal B, HER2 + , and triple negative groups in patients scheduled for NAC due to the axillary lymph node involvement.</description><identifier>ISSN: 0972-2068</identifier><identifier>EISSN: 0973-9793</identifier><identifier>DOI: 10.1007/s12262-022-03633-8</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Breast cancer ; Cardiac Surgery ; Chemotherapy ; Lymphatic system ; Medicine ; Medicine &amp; Public Health ; Neurosurgery ; Original Article ; Pediatric Surgery ; Plastic Surgery ; Surgery ; Thoracic Surgery</subject><ispartof>Indian journal of surgery, 2023-02, Vol.85 (1), p.113-119</ispartof><rights>Association of Surgeons of India 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-c11a1965cc5f5b6ac17ef42176711c0ae80a8171a50818c090874a0ed93857e3</cites><orcidid>0000-0003-2682-8570</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12262-022-03633-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12262-022-03633-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,782,786,27933,27934,41497,42566,51328</link.rule.ids></links><search><creatorcontrib>Koca, Bulent</creatorcontrib><creatorcontrib>Yildirim, Murat</creatorcontrib><creatorcontrib>Ugurlu, Celil</creatorcontrib><creatorcontrib>Bostan, Mustafa Sami</creatorcontrib><creatorcontrib>Başak, Mustafa</creatorcontrib><creatorcontrib>Dasıran, Mehmet Fatih</creatorcontrib><creatorcontrib>Özcan, Namık</creatorcontrib><title>Factors Affecting Axillary Complete Response After Neoadjuvant Chemotherapy and the Importance of Ki-67 Level</title><title>Indian journal of surgery</title><addtitle>Indian J Surg</addtitle><description>We determined independent predictive factors influencing axillary response in patients with neoadjuvant chemotherapy (NAC) indication due to axillary metastases. The patients with T1-4, N1, and M0 tumors who underwent NAC were selected. The study included 105 patients, all women. The factors to be investigated for their effect on the axillary response to NAC were determined as the following: menopausal status (premenopause, postmenopause), pathological diagnosis (invasive ductal ca, other), radiological tumor size (T1 &lt; 2 cm, T2 ≥ 2- &lt; 5 cm, T3 ≥ 5 cm), estrogen receptor (positive, negative), progesterone receptor (positive, negative), HER2 (positive, negative), Ki-67 (cut-off 14%), Ki-67 (cut-off 25%), luminal A, luminal B, HER 2-positive groups, triple-negative group, the number of positive lymph nodes in the axilla before NAC (1, &gt; 1), multifocal tumor, and inflammatory breast cancer. The axillary response to NAC was detected to be lower in ER + ( p  = 0.001), PR + ( p  = 0.002), luminal A ( p  &lt; 0.001), the number of pathological lymph nodes before NAC &gt; 1 ( p  = 0.018), multifocality ( p  = 0.04), and inflammatory breast cancer ( p  = 0.018). We observed that the axillary response to NAC was better in HER2 + ( p  = 0.09), Ki-67 (cut-off 14%) ( p  &lt; 0.001), Ki-67 (cut-off 25) ( p  &lt; 0.001), HER2 + subs type ( p  = 0.023), triple negative subtype ( p  = 0.046). According to the results of the multivariate logistic regression test performed Ki-67 (cut-off 25%) ( p  = 0.030) and inflammatory type breast cancer ( p  = 0.013) were found to be independent predictive factors affecting axillary response to NAC. We recommend that the Ki-67 value of 25% be used to predict axillary response in luminal B, HER2 + , and triple negative groups in patients scheduled for NAC due to the axillary lymph node involvement.</description><subject>Breast cancer</subject><subject>Cardiac Surgery</subject><subject>Chemotherapy</subject><subject>Lymphatic system</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurosurgery</subject><subject>Original Article</subject><subject>Pediatric Surgery</subject><subject>Plastic Surgery</subject><subject>Surgery</subject><subject>Thoracic Surgery</subject><issn>0972-2068</issn><issn>0973-9793</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kEFLAzEQhYMoWKt_wFPA8-ok6W6yx1KsFouC9B5iOttu2d2sSVrsvzd2BW8ehnmH771hHiG3DO4ZgHwIjPOCZ8DTiEKITJ2REZRSZKUsxflJ84xDoS7JVQg7AD5J2Ii0c2Oj84FOqwptrLsNnX7VTWP8kc5c2zcYkb5j6F0XMEERPX1FZ9a7_cF0kc622Lq4RW_6IzXdmiZNF23vfDSdReoq-lJnhaRLPGBzTS4q0wS8-d1jspo_rmbP2fLtaTGbLjPLJcTMMmZYWeTW5lX-URjLJFYTzmQhGbNgUIFRTDKTg2LKQglKTgzguhQqlyjG5G6I7b373GOIeuf2vksXNZdSCZ4zKBPFB8p6F4LHSve-btPjmoH-aVUPrerUqj61qlUyicEUEtxt0P9F_-P6BjOMec0</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Koca, Bulent</creator><creator>Yildirim, Murat</creator><creator>Ugurlu, Celil</creator><creator>Bostan, Mustafa Sami</creator><creator>Başak, Mustafa</creator><creator>Dasıran, Mehmet Fatih</creator><creator>Özcan, Namık</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0003-2682-8570</orcidid></search><sort><creationdate>20230201</creationdate><title>Factors Affecting Axillary Complete Response After Neoadjuvant Chemotherapy and the Importance of Ki-67 Level</title><author>Koca, Bulent ; Yildirim, Murat ; Ugurlu, Celil ; Bostan, Mustafa Sami ; Başak, Mustafa ; Dasıran, Mehmet Fatih ; Özcan, Namık</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-c11a1965cc5f5b6ac17ef42176711c0ae80a8171a50818c090874a0ed93857e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Breast cancer</topic><topic>Cardiac Surgery</topic><topic>Chemotherapy</topic><topic>Lymphatic system</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurosurgery</topic><topic>Original Article</topic><topic>Pediatric Surgery</topic><topic>Plastic Surgery</topic><topic>Surgery</topic><topic>Thoracic Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koca, Bulent</creatorcontrib><creatorcontrib>Yildirim, Murat</creatorcontrib><creatorcontrib>Ugurlu, Celil</creatorcontrib><creatorcontrib>Bostan, Mustafa Sami</creatorcontrib><creatorcontrib>Başak, Mustafa</creatorcontrib><creatorcontrib>Dasıran, Mehmet Fatih</creatorcontrib><creatorcontrib>Özcan, Namık</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Indian journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koca, Bulent</au><au>Yildirim, Murat</au><au>Ugurlu, Celil</au><au>Bostan, Mustafa Sami</au><au>Başak, Mustafa</au><au>Dasıran, Mehmet Fatih</au><au>Özcan, Namık</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors Affecting Axillary Complete Response After Neoadjuvant Chemotherapy and the Importance of Ki-67 Level</atitle><jtitle>Indian journal of surgery</jtitle><stitle>Indian J Surg</stitle><date>2023-02-01</date><risdate>2023</risdate><volume>85</volume><issue>1</issue><spage>113</spage><epage>119</epage><pages>113-119</pages><issn>0972-2068</issn><eissn>0973-9793</eissn><abstract>We determined independent predictive factors influencing axillary response in patients with neoadjuvant chemotherapy (NAC) indication due to axillary metastases. The patients with T1-4, N1, and M0 tumors who underwent NAC were selected. The study included 105 patients, all women. The factors to be investigated for their effect on the axillary response to NAC were determined as the following: menopausal status (premenopause, postmenopause), pathological diagnosis (invasive ductal ca, other), radiological tumor size (T1 &lt; 2 cm, T2 ≥ 2- &lt; 5 cm, T3 ≥ 5 cm), estrogen receptor (positive, negative), progesterone receptor (positive, negative), HER2 (positive, negative), Ki-67 (cut-off 14%), Ki-67 (cut-off 25%), luminal A, luminal B, HER 2-positive groups, triple-negative group, the number of positive lymph nodes in the axilla before NAC (1, &gt; 1), multifocal tumor, and inflammatory breast cancer. The axillary response to NAC was detected to be lower in ER + ( p  = 0.001), PR + ( p  = 0.002), luminal A ( p  &lt; 0.001), the number of pathological lymph nodes before NAC &gt; 1 ( p  = 0.018), multifocality ( p  = 0.04), and inflammatory breast cancer ( p  = 0.018). We observed that the axillary response to NAC was better in HER2 + ( p  = 0.09), Ki-67 (cut-off 14%) ( p  &lt; 0.001), Ki-67 (cut-off 25) ( p  &lt; 0.001), HER2 + subs type ( p  = 0.023), triple negative subtype ( p  = 0.046). According to the results of the multivariate logistic regression test performed Ki-67 (cut-off 25%) ( p  = 0.030) and inflammatory type breast cancer ( p  = 0.013) were found to be independent predictive factors affecting axillary response to NAC. We recommend that the Ki-67 value of 25% be used to predict axillary response in luminal B, HER2 + , and triple negative groups in patients scheduled for NAC due to the axillary lymph node involvement.</abstract><cop>New Delhi</cop><pub>Springer India</pub><doi>10.1007/s12262-022-03633-8</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-2682-8570</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0972-2068
ispartof Indian journal of surgery, 2023-02, Vol.85 (1), p.113-119
issn 0972-2068
0973-9793
language eng
recordid cdi_proquest_journals_2778325109
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SpringerNature Journals
subjects Breast cancer
Cardiac Surgery
Chemotherapy
Lymphatic system
Medicine
Medicine & Public Health
Neurosurgery
Original Article
Pediatric Surgery
Plastic Surgery
Surgery
Thoracic Surgery
title Factors Affecting Axillary Complete Response After Neoadjuvant Chemotherapy and the Importance of Ki-67 Level
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T21%3A31%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20Affecting%20Axillary%20Complete%20Response%20After%20Neoadjuvant%20Chemotherapy%20and%20the%20Importance%20of%20Ki-67%20Level&rft.jtitle=Indian%20journal%20of%20surgery&rft.au=Koca,%20Bulent&rft.date=2023-02-01&rft.volume=85&rft.issue=1&rft.spage=113&rft.epage=119&rft.pages=113-119&rft.issn=0972-2068&rft.eissn=0973-9793&rft_id=info:doi/10.1007/s12262-022-03633-8&rft_dat=%3Cproquest_cross%3E2778325109%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2778325109&rft_id=info:pmid/&rfr_iscdi=true